IBRXImmunityBio, Inc.Running, no new patients
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Bladder Cancer
10Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +10
Main results were due Oct 2024, none posted yet
Counts until it's fixed
Worry score10
Score over time
- Stage
- Phase 2/3
- Patients
- 190 (final count)
- Started
- Jun 2, 2017
- Main results expected
- Oct 1, 2024
- Fully finished
- Mar 1, 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Complete Response
Measured over: 60 Months
Disease-Free Rate
Measured over: 12 Months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- results_overdue: base 10, now 10, since 2024-10-01, no fading
Raw record changes
- none yet
Trial ID NCT03022825 · record last updated 2025-10-16 · checked 2026-11-09 15:47 UTC